Arkolith/Insider Trading/LXEO/Form 4

Otero Jose Manuel

Chief Technical OfficerLexeo Therapeutics, Inc. (LXEO) · full profile →Form 4 · filed Oct 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19K
Net Open-Market Flow
-$19K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2025Sell(S)2K$8.94$19K64K
Oct 17, 2025Sell(S)24$9.56$22964K
Oct 15, 2025Grant(A)6K—$066K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002024096-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Lexeo Therapeutics, Inc.

Build

Ask your agent about LXEO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0002024096-25-000003"
Ask your agent
Use Arkolith to summarize insider buying and selling at Lexeo Therapeutics, Inc.
over the last 90 days and cite the filings.